These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 16034060)
1. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. Alliot C J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060 [No Abstract] [Full Text] [Related]
2. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. Doorduijn JK; van der Holt B; van Imhoff GW; van der Hem KG; Kramer MH; van Oers MH; Ossenkoppele GJ; Schaafsma MR; Verdonck LF; Verhoef GE; Steijaert MM; Buijt I; Uyl-de Groot CA; van Agthoven M; Mulder AH; Sonneveld P J Clin Oncol; 2003 Aug; 21(16):3041-50. PubMed ID: 12915593 [TBL] [Abstract][Full Text] [Related]
3. [Effect of granulocyte colony-stimulating factor after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection]. Navarro JT; Ribera JM; Gómez-Espuch J; Feliu E Med Clin (Barc); 1996 Jun; 107(3):118-9. PubMed ID: 8754503 [No Abstract] [Full Text] [Related]
4. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma]. Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532 [No Abstract] [Full Text] [Related]
5. [Non-Hodgkin lymphoma]. Ogawa M Gan To Kagaku Ryoho; 1996 Aug; 23(9):1143-8. PubMed ID: 8751801 [TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma. Doorduijn JK; Buijt I; van der Holt B; van Agthoven M; Sonneveld P; Uyl-de Groot CA Haematologica; 2004 Sep; 89(9):1109-17. PubMed ID: 15377472 [TBL] [Abstract][Full Text] [Related]
8. Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study. Niitsu N; Iijima K Ann Hematol; 2001 Oct; 80(10):602-6. PubMed ID: 11732872 [TBL] [Abstract][Full Text] [Related]
9. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice]. van Agthoven M; Wittebol S; Budel LM; Uyl-de Groot CA; Kramer MH Ned Tijdschr Geneeskd; 2004 Jan; 148(2):88-93. PubMed ID: 14753131 [TBL] [Abstract][Full Text] [Related]
10. [High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma]. Taguchi H; Shishido T; Niitsu N; Hiraoka A; Kageyama T; Kanamaru A; Ogawa M Gan To Kagaku Ryoho; 1998 Mar; 25(4):523-9. PubMed ID: 9530358 [TBL] [Abstract][Full Text] [Related]
11. Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old. Italiano A; Jardin F; Peyrade F; Saudes L; Tilly H; Thyss A Haematologica; 2005 Sep; 90(9):1281-3. PubMed ID: 16154857 [TBL] [Abstract][Full Text] [Related]
12. [Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients]. Izumi T; Muroi K; Hoshino Y; Komatsu N; Ohtsuki T; Yamada M; Tomizuka H; Hatake K; Furusawa S; Miura Y Gan To Kagaku Ryoho; 1996 May; 23(6):797-800. PubMed ID: 8645033 [No Abstract] [Full Text] [Related]
13. Clinical trials for malignant lymphoma in Japan. Tobinai K; Hotta T Jpn J Clin Oncol; 2004 Jul; 34(7):369-78. PubMed ID: 15342663 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas. Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447 [No Abstract] [Full Text] [Related]
15. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma]. Yuan ZY; Xu RH; He YJ; Guan ZZ Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor. Hernàndez DE; Hernàndez AE Eur J Cancer Care (Engl); 2006 Dec; 15(5):493-6. PubMed ID: 17177909 [TBL] [Abstract][Full Text] [Related]
17. [Dose reduction is not recommended for elderly patients undergoing chemotherapy for non-Hodgkin lymphoma]. Sonneveld P; Huijgens PC; Hagenbeek A Ned Tijdschr Geneeskd; 1999 Feb; 143(8):418-9. PubMed ID: 10221113 [TBL] [Abstract][Full Text] [Related]
18. Retrospective comparison between CHOP-PVP and CHOP protocols for non-Hodgkin's lymphoma. Gan H; Zhang F; Lin Y Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):397-9. PubMed ID: 12408775 [TBL] [Abstract][Full Text] [Related]
19. The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates. Peters FP; Fickers MM; Erdkamp FL; Wals J; Wils JA; Schouten HC Ann Hematol; 2001 Jul; 80(7):406-10. PubMed ID: 11529466 [TBL] [Abstract][Full Text] [Related]
20. CHOP versus intensive regimens in non-Hodgkin's lymphoma. Salloum E; Levin M N Engl J Med; 1993 Aug; 329(8):581; author reply 581-2. PubMed ID: 8336764 [No Abstract] [Full Text] [Related] [Next] [New Search]